These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33960047)

  • 1. Effects of dupilumab treatment on patch test reactions: A retrospective evaluation.
    de Wijs LEM; van der Waa JD; Nijsten T; Silverberg JI; Kunkeler ACM; Hijnen DJ
    Clin Exp Allergy; 2021 Jul; 51(7):959-967. PubMed ID: 33960047
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review.
    Raffi J; Suresh R; Botto N; Murase JE
    J Am Acad Dermatol; 2020 Jan; 82(1):132-138. PubMed ID: 31562940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of Residual Facial Dermatitis during Dupilumab Therapy: A Retrospective Chart Review to Delineate the Potential Role of Expanded Series Patch Testing.
    Ashbaugh AG; Murase EM; Raffi J; Botto N; Murase JE
    Dermatitis; 2022 Jan-Feb 01; 33(1):51-61. PubMed ID: 35029349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab for allergic contact dermatitis and implications for patch testing: Irreconcilable differences.
    Shah P; Milam EC; Lo Sicco KI; Cohen DE
    J Am Acad Dermatol; 2020 Sep; 83(3):e215-e216. PubMed ID: 32417419
    [No Abstract]   [Full Text] [Related]  

  • 6. Patch Testing in a Patient on Dupilumab.
    Hoot JW; Douglas JD; Falo LD
    Dermatitis; 2018; 29(3):164. PubMed ID: 29570490
    [No Abstract]   [Full Text] [Related]  

  • 7. Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis.
    Stout M; Silverberg JI
    J Am Acad Dermatol; 2019 Jul; 81(1):157-162. PubMed ID: 30885752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab for Allergic Contact Dermatitis: An Overview of Its Use and Impact on Patch Testing.
    Johnson H; Adler BL; Yu J
    Cutis; 2022 May; 109(5):265-267. PubMed ID: 35856769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema.
    Crepy MN; Nosbaum A; Bensefa-Colas L
    Contact Dermatitis; 2019 Aug; 81(2):145-147. PubMed ID: 30851059
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study.
    Bocquel S; Soria A; Raison-Peyron N; Badaoui A; Marcant P; Bara C; Giordano-Labadie F; Amsler E; Milpied B; Delaunay J; Darrigade AS; Pralong P; Boulard C; Ferrier Le Bouedec MC; Tauber M; Pasteur J; Valois A; Le Thuaut A; Crépy MN; Bernier C
    J Am Acad Dermatol; 2024 Mar; 90(3):512-520. PubMed ID: 37871801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
    Yamane MLM; Belsito DV; Glass LRD
    Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis.
    Malajian D; Belsito DV
    J Am Acad Dermatol; 2013 Aug; 69(2):232-7. PubMed ID: 23583066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG).
    Löffler H; Becker D; Brasch J; Geier J;
    Br J Dermatol; 2005 Apr; 152(4):709-19. PubMed ID: 15840103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recall dermatitis at patch test sites in an atopic dermatitis patient treated with dupilumab.
    Collantes-Rodríguez C; Jiménez-Gallo D; Ossorio-García L; Villegas-Romero I; Linares-Barrios M
    Contact Dermatitis; 2019 Jan; 80(1):69-70. PubMed ID: 30334260
    [No Abstract]   [Full Text] [Related]  

  • 15. Expanded Series and Personalized Patch Tests for Children: A Retrospective Cohort Study.
    Collis RW; Morris GM; Sheinbein DM; Coughlin CC
    Dermatitis; 2020; 31(2):144-146. PubMed ID: 31441780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patch Testing and Allergen-Specific Inhibition in a Patient Taking Dupilumab.
    Raffi J; Botto N
    JAMA Dermatol; 2019 Jan; 155(1):120-121. PubMed ID: 30484816
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of dupilumab on allergic contact dermatitis and patch testing.
    Jo CE; Mufti A; Sachdeva M; Pratt M; Yeung J
    J Am Acad Dermatol; 2021 Jun; 84(6):1772-1776. PubMed ID: 33617912
    [No Abstract]   [Full Text] [Related]  

  • 18. Allergic contact dermatitis from Laurus nobilis oil induced by massage.
    Adişen E; Onder M
    Contact Dermatitis; 2007 Jun; 56(6):360-1. PubMed ID: 17577382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of patch-tests from Santa Casa de Belo Horizonte Dermatology Clinic, Belo Horizonte, Brazil, from 2003 to 2010.
    Rodrigues DF; Neves DR; Pinto JM; Alves MF; Fulgêncio AC
    An Bras Dermatol; 2012; 87(5):800-3. PubMed ID: 23044584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of contact sensitization in patients with and without atopic dermatitis in a hospital-based clinical database.
    Clemmensen KK; Thomsen SF; Jemec GB; Agner T
    Contact Dermatitis; 2014 Aug; 71(2):75-81. PubMed ID: 24697272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.